作者: Iris H. Wei , Julio Garcia-Aguilar
DOI: 10.23736/S0026-4733.18.07743-X
关键词: Colorectal cancer 、 Medicine 、 Survival analysis 、 Tumor biology 、 General surgery 、 Disease 、 Chemoradiotherapy 、 Dose fractionation 、 Chemotherapy 、 Neoadjuvant therapy
摘要: The management of locally-advanced rectal cancer involves a combination chemotherapy, chemoradiation, and surgical resection to provide excellent local tumor control overall survival. However, aspects this multimodality approach are associated with significant morbidity long-term sequelae. In addition, there is growing evidence that patients clinical complete response chemotherapy chemoradiation treatments may be safely offered initial non-operative in rigorous surveillance program. Weighed against the sequelae resection, recognizing how best optimize strategies without compromising oncologic outcomes critical our understanding treatment disease.